lino Biotech AG is the world’s only company specialized in focal molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples.
15.09.2021 - 11:51:38
lino Biotech Can Draw on Over 150 Years of Experience in Life Science, Cell Therapy and Diagnostics Thanks to Five Internationally Renowned Industry Experts. The broadly patented technology offers label-free detection assays while eliminating signal disturbances due to temperature changes or non-specific binding. The company was incorporated in Zürich, Switzerland, in March 2020 with the aim to make cell therapies more cost effective and accessible for a broader patient population by offering new quality control method that every cell therapy manufacturer can use to improve their production and development process.
- was incorporated as ETH Zurich spin-out in Zürich, Switzerland, in March 2020, and is venture backed by Roche Venture Fund, High-Tech Gründerfonds and several life science family offices. lino Biotech is a life science tools company, offering biosensors and readers for complex solution analytics. The entirely new method of measuring molecular interactions enables customers from cell and gene therapy to optimize their R&D and production processes, reduce cost, and improve product quality. In the future, lino´s technology molography will also offer new applications in bioprocessing, diagnostics, and precision medicine.
More informations: www.lino-biotech.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210915005530/en/